Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease
Withdrawn before enrolling
Conditions studied: Bronchopulmonary Dysplasia
In brief
This is a prospective, longitudinal observational study to provide data regarding the natural course of hypercapnia in premature infants with bronchopulmonary dysplasia using both available blood pCO2 and measured capnography, as well as relate the degree and trend of hypercapnia to later respiratory outcomes.
Key facts
- Study ID
- NCT02996162
- Run by
- Boston Children's Hospital
- People needed
- 0
- Starts
- 2020-12-01
- Expected to finish
- 2021-05-06
- Last updated by the study team
- 2021-08-02
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Potential eligible patients will be identified in the first 3-14 days of life at Beth Israel Deaconess Hospital (BIDMC) NICU who have a birth gestational age <=32 0/7 weeks and current or previous requirement for positive pressure (ventilation or continuous positive airway pressure (CPAP).
You may not qualify if…
- death prior to discharge from the NICU,
- chronic lung disease secondary to pulmonary conditions other than bronchopulmonary dysplasia and
- other underlying identified genetic syndromes.
Where it is running
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.